Integra LifeSciences Reports Fourth Quarter 2013 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Integra Lifesciences Holdings (IART) Misses Q4 EPS by 3c
February 25, 2014 6:36 AM ESTIntegra Lifesciences Holdings (NASDAQ: IART) reported Q4 EPS of $0.78, $0.03 worse than the analyst estimate of $0.81. Revenue for the quarter came in at $220.8 million versus the consensus estimate of $223.37 million.
Integra Lifesciences Holdings sees FY2014 revenue of $920-940 million, versus the consensus of $932.3 million.... More
